Eosinophils and neutrophils of human neonates have similar impairments of quantitative up-regulation of Mac-1 (CDllb/CD18) expression in vitro

Pediatric Research

Volumn 30, Issue 4, 1991, Pages 355-361

  Smith, Jeffrey B ^a   Kunjummen, Raju D ^a   Raghavender, Bhupala H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE PROTEIN; GLYCOPROTEIN;

ADULT; CELL FUNCTION; CONFERENCE PAPER; EOSINOPHIL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; NEUTROPHIL; NEWBORN; NEWBORN INFECTION; PRIORITY JOURNAL;

ADULT; AGING; COMPARATIVE STUDY; EOSINOPHILS; HUMAN; INFANT, NEWBORN; MACROPHAGE-1 ANTIGEN; NEUTROPHILS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; UP-REGULATION;

EID: 0026047963     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1203/00006450-199110000-00012     Document Type: Article

References (49)

1. Anderson DC, Springer TA 1987 Leukocyte adhesion deficiency: an inheriteddefect in the Mac-1, LFA-1, and p 150,95 glycoproteins. Annu Rev Med 38:175-194
2. Arnaout MA 1990 Structure and function of the leukocyte adhesion molecules CD11/CD18. Blood 75:1037-1050
3. Carlos TM, Harlan JM 1990 Membrane proteins involved in phagocyte adherence to endothelium. Immunol Rev 114:5-28
4. Springer TA 1990 Adhesion receptors of the immune system. Nature 356:425-434
5. Todd RF III., Arnaout MA, Rosin RE, Crowley CA, Peters WA, Babior BM 1984 Subcellular localization of the large subunit of Mol (Mol-alpha: formerly gp 110), a surface glycoprotein associated with neutrophil adhesion. J Clin Invest 74:1280-1290
6. Berger M, O’Shea J, Cross AS, Folks TM, Chused TM, Brown EJ, Frank MM 1984 Human neutrophils increase expression of C3bi as well as C3b receptors upon activation. J Clin Invest 74:1566-1571
7. Vedder NB, Harlan JM 1988 Increased surface expression of CDllb/CDI8 (Mac-1) is not required for stimulated neutrophil adherence to cultured endothelium. J Clin Invest 81:676-682
8. Wilson CB 1986 Immunological basis for increased susceptibility of the neonate to infection. J Pediatr 108:1-12
9. Hill HR 1987 Biochemical, structural, and functional abnormalities of polymorphonuclear leukocytes in the neonate. Pediatr Res 22:375-382
10. Bruce MC, Baley JE, Medvik KA, Berger M 1987 Impaired surface membrane expression of C3bi but not C3b receptors on neonatal neutrophils. Pediatr Res 21:306-311
11. Anderson DC, Freeman KLB, Heerdt B, Hughes BJ, Jack RM, Smith CW 1987 Abnormal stimulated adherence of neonatal granulocytes: impaired induction of surface MAC-1 by chemotactic factors or secretagogues. Blood 70:740-750
12. Smith JB, Campbell DE, Ludomirsky A, Polin RA, Douglas SD, Garty BZ, Harris MC 1990 Expression of the complement receptors CR1 and CR3 and the type III FC7 receptor on neutrophils from newborn infants and from fetuses with Rh disease. Pediatr Res 28:120-126
13. Anderson DC, Rothlein R, Marlin SD, Krater SS, Smith CW 1990 Impaired transendothelial migration by neonatal neutrophils: abnormalities of Mac-1 (CD1 lb/CD18)-dependent adherence reactions. Blood 76:2613-2621
14. Anderson DC, Abbassi O, Kishimoto TIC, Mclntire LV, Smith CW 1990 Diminished human MEL-14 antigen on neonatal neutrophils underlies impaired CD1 l/CD18-independent adhesion to endothelial cells. Pediatr Res 27:153A(abstr)
15. Yazdanbakhsh M, Eckmann CM, Roos D 1985 Characterization of the interaction of human eosinophils and neutrophils with opsonized particles. J Immunol 135:1378-1384
16. Fischer E, Capron M, Prin L, Kusinerz JP, Kazatchkine MD 1986 Human eosinophils express CR1 and CR3 complement receptors for cleavage fragments of C3. Cell Immunol 97:297-306
17. Hartnell A, Moqbel R, Walsh GM, Bradley B, Kay AB 1990 FC7 and CD11/ CD 18 receptor expression on normal density and low density human eosinophils. Immunology 69:264-270
18. Slungaard A, Vercellotti GM, Walker G, Nelson RD, Jacob HS 1990 Tumor necrosis factor a/cachectin stimulates eosinophil oxidant production and toxicity towards human endothelium. J Exp Med 171:2025-2041
19. Thorne KJI, Richardson BA, Mazza G, Butterworth AE 1990 A new method for measuring eosinophil activating factors, based on the increased expression of CR3 a-chain (CD1 lb) on the surface of activated eosinophils. J Immunol Methods 133:47-54
20. Lamas AM, Mulroney CM, Schleimer RP 1988 Studies on the adhesive interaction between purified human eosinophils and cultured vascular endothelial cells. J Immunol 140:1500-1505
21. Walsh GM, Hartnell A, Wardlaw AJ, Kurihara K, Sanderson CJ, Kay AB 1990 IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leucocyte integrin (CD1 l/18)-dependent manner. Immunology 71:258-265
22. Roberts RL, Gallin JI 1985 Rapid method for isolation of normal human peripheral blood eosinophils on discontinuous Percoll gradients and comparison with neutrophils. Blood 65:433-440
23. Terstappen LWMM, Hollander Z, Meiners H, Loken MR 1990 Quantitative comparison of myeloid antigens on five lineages of mature peripheral blood cells. J Leukocyte Biol 48:138-148
24. Fearon DT, Collins LA 1983 Increased expression of C3b receptors on polymorphonuclear leukocytes induced by chemotactic factors and by purification procedures. J Immunol 130:370-375
25. Jones DH, Schmalstieg FC, Kempsey FT, Krater SS, Nannen DD, Smith CW, Anderson DC 1990 Subcellular distribution and mobilization of MAC-1 (CD1 lb/CD18) in neonatal neutrophils. Blood 75:488-498
26. Gibson EL, Vaucher Y, Corrigan JJ 1979 Eosinophilia in premature infants: relationship to weight gain. J Pediatr 95:99-101
27. Bhat AM, Scanlon JW 1981 The pattern of eosinophilia in premature infants. J Pediatr 98:612-616
28. Kulczycki A Jr. 1984 Human neutrophils and eosinophils have structurally distinct Fc gamma receptors. J Immunol 133:849-854
29. Looney RJ, Ryan DH, Takahashi K, Fleit HB, Cohen HJ, Abraham GN, Anderson CL 1986 Identification of a second class of IgG receptors on human neutrophils: a 40 kilodalton molecule also found on eosinophils. J Exp Med 163:826-836
30. Graziano RF, Looney SJ, Shen L, Fanger MW 1989 FcYR-mediated killing by eosinophils. J Immunol 142:230-235
31. Hansel TT, Pound JD, Pilling D, Kitas GD, Salmon M, Gentle TA, Lee SS, Thompson RA 1989 Purification of human blood eosinophils by negative selection using immunomagnetic beads. J Immunol Methods 122:97-103
32. Kunjummen RD, Raghavender BH, Walker DK, Smith JB 1990 Neonatal eosinophils have a defect in CDllb/CD18 expression similar to neonatal neutrophils. Pediatr Res 27:267A(abstr)
33. Hansel TT, Pound JD, Thompson RA 1990 Isolation of eosinophils from human blood. J Immunol Methods 127:153-164
34. Ory PA, Goldstein IM, Kwoh EE, Clarkson SB 1989 Characterization of polymorphic forms of Fc receptor III on human neutrophils. J Clin Invest 83:1676-1681
35. Huizinga TWJ, van der Shoot CE, Jost C, Klaassen R, Kleijer M, von dem Borne AEGKr, Roos D, Tetteroo PAT 1988 The Pl-linked receptor FcRlH is released on stimulation of neutrophils. Nature 333:667-669
36. Selvaraj P, Rosse WF, Silber R, Springer T 1988 The major Fc receptor in blood has a phosphatidylinositol anchor and is deficient in paroxysmal nocturnal hemoglobinuria. Nature 333:565-567
37. Boros P, Gardos E, Bekesi GJ, Unkeless JC 1990 Change in expression of FC7RIH (CD16) on neutrophils from human immunodeficiency virus-infected individuals. Clin Immunol Immunopathol 54:281-289
38. Strauss RG, Snyder EL 1983 Activation and activity of the superoxidegenerating system of neutrophils from human infants. Pediatr Res 17:662-664
39. Ambruso DR, Stork LC, Gibson BE, Thurman GW 1987 Increased activity of the respiratory burst in cord blood neutrophils: kinetics of the NADPH oxidase enzyme system in subcellular fractions. Pediatr Res 21:205-210
40. Fletcher MP, Seligmann BE 1985 Monitoring human neutrophil granulesecretion by flow cytometry: secretion and membrane potential assessed by light scatter and a fluorescent probe of membrane potential. J Leukocyte Biol 37:431-447
41. Klebanoff SJ, Durack DT, Rosen H, Clark RA 1977 Functional studies on human peritoneal eosinophils. Infect Immun 17:167-173
42. Wardlaw AJ, Moqbel R, Cromwell O, Kay AB 1986 Platelet activating factor:a potent chemotactic and chemokinetic factor for human eosinophils. J Clin Invest 78:1701-1706
43. Hayashi K. 1989 Comparative study on the responses of human neutrophils and eosinophils to platelet-activating factor. J Clin Biochem Nutr 6:77-86
44. Yukawa T, Kroegel C, Evans P, Fukuda T, Chung KF, Barnes PJ 1989 Density heterogeneity of eosinophil leukocytes: induction of hypodense eosinophils by platelet-activating factor. Immunology 68:140-143
45. Giembycz MA, Kroegel C, Barnes PJ 1990 Platelet activating factor stimulates cyclooxygenase activity in guinea pig eosinophils. J Immunol 144:3489-3497
46. Gerard NP, Hodges MK, Drazen JM, Weller PF, Gerard C 1989 Characterization of a receptor for C5a anaphylatoxin on human eosinophils. J Biol Chem 264:1760-1766
47. Koenderman L, Kok PTM, Hamelink ML, Verhoeven AJ, Bruijnzeel PLB 1988 An improved method for the isolation of eosinophilic granulocytes from peripheral blood of normal individuals. J Leukocyte Biol 44:79-86
48. Anwar ARE, Kay AB 1977 The ECF-A tetrapeptides and histamine selectively enhance human eosinophil complement receptors. Nature 269:522-524
49. Anwar ARE, Kay AB 1978 Enhancement of human eosinophil complementreceptors by pharmacological mediators. Infect Immun 121:1245-1250